Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome

American Journal of Cardiology

Volumn 113, Issue 5, 2014, Pages 888-896

  Ice, Daniel S ^a   Shapiro, Timothy A ^a   Gnall, Eric M ^a   Kowey, Peter R ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; COMORBIDITY; DRUG THERAPY, COMBINATION; FACTOR XA; HUMANS; MORPHOLINES; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PYRAZOLES; PYRIDONES; RISK ASSESSMENT; STROKE; THIOPHENES; THROMBOSIS; TICLOPIDINE;

EID: 84893901027     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.11.046     Document Type: Review

References (76)

1. N. Mackman, and R.C. Becker DVT: a new era in anticoagulant therapy Arterioscler Thromb Vasc Biol 30 2010 369 371
2. ACTIVE Writing Group of the ACTIVE Investigators S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, M. Pfeffer, S. Hohnloser, and S. Yusef Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
3. N. Turgut, O. Akdemir, B. Turgut, M. Demir, G. Ekuklu, O. Vural, G. Ozybay, and U. Utku Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations Clin Appl Thromb Hemost 12 2006 15 20
4. F. Marín, V. Roldán, V.E. Climent, A. Ibáñez, A. García, P. Marco, F. Sogorb, and G.Y. Lip Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation Heart 90 2004 1162 1166
5. S. Goto, D.L. Bhatt, J. Rother, M. Alberts, M.D. Hill, Y. Ikeda, S. Uchiyama, R. D'Agostino, E.M. Ohman, C.S. Liau, A.T. Hirsch, J.L. Mas, P.W. Wilson, R. Corbalán, F. Aichner, P.G. Steg REACH Registry Investigators Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Am Heart J 156 2008 855 863
6. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
7. N. Mackman Triggers, targets, and treatments of thrombosis Nature 451 2008 914 918
8. R. Rossini, G. Musumeci, C. Lettieri, M. Molfese, L. Mihalcsik, P. Mantovani, V. Sirbu, T.A. Bass, F. Della Rovere, A. Gavazzi, and D. Angiolillo Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy Am J Cardiol 102 2008 1618 1623
9. A. Rubboli, M. Colletta, J. Valencia, A. Capecchi, N. Franco, L. Zanolla, L. La Vecchia, G. Piovaccari, G. Di Pasquale WARfarin and Coronary STENTing (WAR-STENT) Study Group Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting J Interv Cardiol 22 2009 390 397
10. T.Y. Wang, L.A. Robinson, F.S. Ou, M.T. Roe, E.M. Ohman, W.B. Gibler, S.C. Smith Jr., E.D. Peterson, and R.C. Becker Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry Am Heart J 155 2008 361 368
11. D.R. Holmes Jr., D.J. Kereiakes, N.S. Kleiman, D.J. Moliterno, G. Patti, and C.L. Grines Combining antiplatelet and anticoagulant therapies J Am Coll Cardiol 54 2009 95 109
12. R. Sørensen, M.L. Hansen, S.Z. Abildstrom, A. Hvelplund, C. Andersson, C. Jørgensen, J.K. Madsen, P.R. Hansen, L. Køber, C. Torp-Pedersen, and G.H. Gislason Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
13. W.J. Dewilde, T. Oirbans, F.W. Verheugt, J.C. Kelder, B.J. De Smet, J.P. Herrman, T. Adriaenssens, M. Vrolix, A.A. Heestermans, M.M. Vis, J.G. Tijsen, A.W. van 't Hof, J.M. ten Berg WOEST study investigators Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
14. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, G.N. Kay, J.Y. Le Huezey, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, L.S. Wann, S.C. Smith Jr., S.G. Priori, N.A. Estes 3rd, M.D. Ezekowitz, W.M. Jackman, C.T. January, J.E. Lowe, R.L. Page, D.J. Slotwiner, W.G. Stevenson, C.M. Tracy, A.K. Jacobs, J.L. Anderson, N. Albert, C.E. Buller, M.A. Creager, S.M. Ettinger, R.A. Guyton, J.L. Halperin, J.S. Hochman, F.G. Kushner, E.M. Ohman, W.G. Stevenson, L.G. Tarkington, C.W. Yancy American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e269 e367
15. Y. Bejot, D. Ben Salem, G.V. Osseby, G. Couvreur, J. Durier, C. Marie, Y. Cottin, T. Moreau, and M. Giroud Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006 Neurology 72 2009 346 353
16. S. Kamath, A.D. Blann, B.S. Chin, F. Lanza, B. Aleil, J.P. Cazenave, and G.Y. Lip A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy Eur Heart J 23 2002 1788 1795
17. D.E. Singer, Y. Chang, M.C. Fang, L.H. Borowsky, N.K. Pomernacki, N. Udaltsova, and A.S. Go The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
18. J.B. Olesen, G.Y.H. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, J. Lindhardsen, C. Selmer, O. Ahlehoff, A.M. Olsen, G.H. Gislason, and C. Torp-Pedersen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
19. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J.G.M. Crijns, and G.Y.H. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation Chest 138 2010 1093 1100
20. R.L. McNamara, L.J. Tamariz, J.B. Segal, and E.B. Bass Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography Ann Intern Med 139 2003 1018 1033
21. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
22. Active Investigators S.J. Connolly, J. Pogue, R.G. Hart, S.H. Hohnloser, M. Pfeffer, S. Chrolavicius, and S. Yusuf Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
23. Y. Yeghiazarians, J.B. Braunstein, A. Askari, and P.H. Stone Unstable angina pectoris N Engl J Med 342 2000 101 114
24. P. Libby The molecular mechanisms of the thrombotic complications of atherosclerosis J Intern Med 263 2008 517 527
25. M. Gawaz, F.J. Neumann, I. Ott, A. May, and A. Schömig Platelet activation and coronary stent implantation. Effect of antithrombotic therapy Circulation 94 1996 279 285
26. G. Nakazawa, E. Ladich, A.V. Finn, and R. Virmani Pathophysiology of vascular healing and stent mediated arterial injury Euro Intervention 4 Suppl C 2008 C7 10
27. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
28. G. Nakazawa, A.V. Finn, M. Joner, E. Ladich, R. Kutys, E.K. Mont, H.K. Gold, A.P. Burke, F.D. Kolodgie, and R. Virmani Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
29. J.L. Orford, R. Lennon, S. Melby, P. Fasseas, M.R. Bell, C.S. Rihal, D.R. Holmes, and P.B. Berger Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry J Am Coll Cardiol 40 2002 1567 1572
30. P. Wenaweser, C. Rey, F.R. Eberli, M. Togni, D. Tüller, S. Locher, A. Remondino, C. Seiler, O.M. Hess, B. Meier, and S. Windecker Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome Eur Heart J 26 2005 1180 1187
31. C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M.C. Morice, A. Schömig, M.E. Pfisterer, G.W. Stone, M.B. Leon, J.S. de Lezo, J.J. Goy, S.J. Park, M. Sabaté, M.J. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M.T. Dirksen, P. Cervinka, A.S. Petronio, A.J. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, and P. Jüni Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
32. J. Aoki, A.J. Lansky, R. Mehran, J. Moses, M.E. Bertrand, B.T. McLaurin, D.A. Cox, A.M. Lincoff, E.M. Ohman, H.D. White, H. Parise, M.B. Leon, and G.W. Stone Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
33. E.J. Armstrong, D.N. Feldman, T.Y. Wang, L.A. Kaltenbach, K.K. Yeo, S.C. Wong, J. Spertus, R.E. Shaw, R.M. Minutello, I. Moussa, K.K. Ho, J.H. Rogers, and K.A. Shunk Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis JACC Cardiovasc Interv 5 2012 131 140
34. J.M. de la Torre-Hernández, F. Alfonso, F. Hernandez, J. Elizaga, M. Sanmartin, E. Pinar, I. Lozano, J.M. Vazquez, J. Botas, A. Perez de Prado, J.M. Hernández, J. Sanchis, J.M. Nodar, A. Gomez-Jaume, M. Larman, J.A. Diarte, J. Rodríguez-Collado, J.R. Rumoroso, J.R. Lopez-Minguez, J. Mauri ESTROFA Study Group Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 2008 986 990
35. D.P. Faxon, J.W. Eikelboom, P.B. Berger, D.R. Holmes, D.L. Bhatt, D.J. Moliterno, R.C. Becker, and D.J. Angiolillo Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective Thromb Haemost 106 2011 572 584
36. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
37. J.W. van Werkum, A.A. Heestermans, A.C. Zomer, J.C. Kelder, M.J. Suttorp, B.J. Rensing, J.J. Koolen, B.R. Brueren, J.H. Dambrink, R.W. Hautvast, F.W. Verheugt, and J.M. ten Berg Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
38. F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave, L. Buellesfeld, E. Bonizzoni, M. Carlino, U. Gerckens, C. Godino, G. Melzi, I. Michev, M. Montorfano, G.M. Sangiorgi, A. Qasim, A. Chieffo, C. Briguori, and E. Grube Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754
39. D.E. Kandzari, D.J. Angiolillo, M.J. Price, and P.S. Teirstein Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization JACC Cardiovasc Interv 2 2009 1279 1285
40. J.Y. Hahn, Y.B. Song, J.H. Choi, S.H. Choi, S.Y. Lee, H.S. Park, S.H. Hur, S. Lee, K.R. Han, S.W. Rha, B.R. Cho, J.S. Park, J. Yoon, S. Lim do, S.H. Lee, H.C. Gwon DATE Registry Investigators Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent) registry Circ J 74 2010 2314 2321
41. M.-K. Hong, B.K. Kim, D.H. Shin, C.M. Nam, J.S. Kim, Y.G. Ko, D. Choi, T.S. Kang, B.E. Park, W.C. Kang, S.H. Lee, J.H. Yoon, B.K. Hong, H.M. Kwon, Y. Jang RESET Investigators A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3 months dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) JACC 60 2012 1340 1348
42. M. Valgimigli, G. Campo, M. Monti, P. Vranckx, G. Percoco, C. Tumscitz, F. Castriota, F. Colombo, M. Tebaldi, G. Fucà, M. Kubbajeh, E. Cangiano, M. Minarelli, A. Scalone, C. Cavazza, A. Frangione, M. Borghesi, J. Marchesini, G. Parrinello, R. Ferrari Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
43. L.S. Wann, A.B. Curtis, C.T. January, K.A. Ellenbogen, J.E. Lowe, N.A. Estes 3rd, R.L. Page, M.D. Ezekowitz, D.J. Slotwiner, W.M. Jackman, W.G. Stevenson, C.M. Tracy 2011 Writing Group Members V. Fuster, L.E. Rydén, D.S. Cannom, J.Y. Le Heuzey, H.J. Crijns, J.E. Lowe, A.B. Curtis, S. Olsson, K.A. Ellenbogen, E.N. Prystowsky, J.L. Halperin, J.L. Tamargo, G.N. Kay, L. Wann 2006 Writing Committee Members A.K. Jacobs, J.L. Anderson, N. Albert, J.S. Hochman, C.E. Buller, F.G. Kushner, M.A. Creager, E.M. Ohman, S.M. Ettinger, W.G. Stevenson, R.A. Guyton, L.G. Tarkington, J.L. Halperin, C.W. Yancy ACCF/AHA Task Force Members 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 104 123
44. A.J. Camm, G.Y.H. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, P. Kirchhof ESC Committee for Practice Guidelines (CPG) 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
45. H. Jneid, J.L. Anderson, R.S. Wright, C.D. Adams, C.R. Bridges, D.E. Casey Jr., S.M. Ettinger, F.M. Fesmire, T.G. Ganiats, A.M. Lincoff, E.D. Peterson, G.J. Philippides, P. Theroux, N.K. Wenger, and J.P. Zidar 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 645 681
46. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, J.L. Anderson, A.K. Jacobs, J.L. Halperin, N.M. Albert, R.G. Brindis, M.A. Creager, D. DeMets, R.A. Guyton, J.S. Hochman, R.J. Kovacs, F.G. Kushner, E.M. Ohman, W.G. Stevenson, C.W. Yancy American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 e362 e425
47. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blömstrom-Lundqvist, M.A. Borger, C. Di Mario, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A.H. Gershlick, P. Giannuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M.J. Lenzen, K.W. Mahaffey, M. Valgimigli, A. van 't Hof, P. Widimsky, and D. Zahger ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Eur Heart J 33 2012 2569 2619
48. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, D. Zahger ESC Committee for Practice Guidelines ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
49. G.Y.H. Lip, K. Huber, F. Andreotti, H. Arnesen, J.K. Airaksinen, T. Cuisset, P. Kirchhof, F. Marín Consensus Document of European Society of Cardiology Working Group on Thrombosis Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a consensus document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
50. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, M. Hamon, G.D. Dangas, A.M. Lincoff, H.D. White, J.W. Moses, S.B. King 3rd, E.M. Ohman, and G.W. Stone Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368
51. S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, F. Van de Werf, K.W. Mahaffey, R.M. Califf, and R.A. Harrington Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
52. J.L. Orford, P. Fasseas, S. Melby, K. Burger, S.R. Steinhubl, D.R. Holmes, and P.B. Berger Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation Am Heart J 147 2004 463 467
53. Z. Khurram, E. Chou, R. Minutello, G. Bergman, M. Parikh, S. Naidu, S.C. Wong, and M.K. Hong Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding J Invasive Cardiol 18 2006 162 164
54. A. Porter, Y. Konstantino, Z. Iakobishvili, L. Shachar, A. Battler, and D. Hasdai Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention Catheter Cardiovasc Interv 68 2006 56 61
55. D. DeEugenio, L. Kolman, M. DeCaro, J. Andrel, I. Chervoneva, P. Duong, L. Lam, C. McGowan, G. Lee, M. DeCaro, N. Ruggiero, S. Singhal, and A. Greenspon Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy Pharmacotherapy 27 2007 691 696
56. S. Manzano-Fernández, F.J. Pastor, F. Marín, F. Cambronero, C. Caro, D.A. Pascual-Figal, I.P. Garrido, E. Pinar, M. Valdés, and G.Y. Lip Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting Chest 134 2008 559 567
57. J.S. Paikin, D.S. Wright, M.A. Crowther, S.R. Mehta, and J.W. Eikelboom Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents Circulation 121 2010 2067 2070
58. M. Lamberts, J.B. Olesen, M.H. Ruwald, C.M. Hansen, D. Karasoy, S.L. Kristensen, L. Køber, C. Torp-Pedersen, G.H. Gislason, and M.L. Hansen Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study Circulation 126 2012 1185 1193
59. S.J. Mattichak, P.S. Reed, M.J. Gallagher, J.A. Boura, W.W. O'Neill, and J.K. Kahn Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction J Interv Cardiol 18 2005 163 166
60. J.M. Ruiz-Nodar, F. Marín, J.A. Hurtado, J. Valencia, E. Pinar, J. Pineda, J.R. Gimeno, F. Sogorb, M. Valdés, and G.Y. Lip Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis J Am Coll Cardiol 51 2008 818 825
61. J.M. Ruiz-Nodar, F. Marín, V. Roldán, J. Valencia, S. Manzano-Fernández, L. Caballero, J.A. Hurtado, F. Sogorb, M. Valdés, and G.Y. Lip Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv 5 2012 459 466
62. M. Moscucci, K.A. Fox, C.P. Cannon, W. Klein, J. López- Sendón, G. Montalescot, K. White, and R.J. Goldberg Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
63. M.E. Bertrand, J.P. Collet, and G. Montalescot Non-ST-segment elevation acute coronary syndromes: an algorithm for decision Eur Heart J 29 2008 279 280
64. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, and S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
65. N.S. Abraham, M.A. Hlatky, E.M. Antman, D.L. Bhatt, D.J. Bjorkman, C.B. Clark, C.D. Furberg, D.A. Johnson, C.J. Kahi, L. Laine, K.W. Mahaffey, E.M. Quigley, J. Scheiman, L.S. Sperling, and G.F. Tomaselli ACCF/ACG/AHA. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Circulation 122 2010 2619 2633
66. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
67. N. Sarafoff, A. Martischnig, J. Wealer, K. Mayer, J. Mehilli, D. Sibbing, and A. Kastrati Triple therapy with aspirin, prasugrel and vitamin K antagonists in patients with drug eluting stent implantation and an indication for oral anticoagulation J Am Coll Cardiol 61 2013 2060 2066
68. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington PLATO Investigators A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
69. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, L. Wallentin RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
70. A.L. Dans, S.J. Connolly, L. Wallentin, S. Yang, J. Nakamya, M. Brueckmann, M. Ezekowitz, J. Oldgren, J.W. Eikelboom, P.A. Reilly, and S. Yusuf Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial Circulation 127 2013 634 640
71. J. Oldgren, A. Budaj, C.B. Granger, Y. Khder, J. Roberts, A. Siegbahn, J.G. Tijssen, F. Van de Werf, L. Wallentin RE-DEEM Investigators Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Eur Heart J 32 2011 2781 2789
72. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, R.M. Califf ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
73. J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode, P. Burton, M. Cohen, N. Cook-Bruns, K.A. Fox, S. Goto, S.A. Murphy, A.N. Plotnikov, D. Schneider, X. Sun, F.W. Verheugt, C.M. Gibson ATLAS ACS 2-TIMI 51 Investigators Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
74. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, H.R. Al-Khalidi, J. Ansell, D. Atar, A. Avezum, M.C. Bahit, R. Diaz, J.D. Easton, J.A. Ezekowitz, G. Flaker, D. Garcia, M. Geraldes, B.J. Gersh, S. Golitsyn, S. Goto, A.G. Hermosillo, S.H. Hohnloser, J. Horowitz, P. Mohan, P. Jansky, B.S. Lewis, J.L. Lopez-Sendon, P. Pais, A. Parkhomenko, F.W. Verheugt, J. Zhu, L. Wallentin ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
75. J.H. Alexander, R.D. Lopes, S. James, R. Kilaru, Y. He, P. Mohan, D.L. Bhatt, S. Goodman, F.W. Verheugt, M. Flather, K. Huber, D. Liaw, S.E. Husted, J. Lopez-Sendon, R. De Caterina, P. Jansky, H. Darius, D. Vinereanu, J.H. Cornel, F. Cools, D. Atar, J.L. Leiva-Pons, M. Keltai, H. Ogawa, P. Pais, A. Parkhomenko, W. Ruzyllo, R. Diaz, H. White, M. Ruda, M. Geraldes, J. Lawrence, R.A. Harrington, L. Wallentin APPRAISE-2 Investigators Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
76. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, A. Avezum, P. Widimsky, P.G. Steg, J.P. Bassand, G. Montalescot, C. Macaya, G. Di Pasquale, K. Niemela, A.E. Ajani, H.D. White, S. Chrolavicius, P. Gao, K.A. Fox, S. Yusuf CURRENT-OASIS 7 trial investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243